Attached files
| file | filename |
|---|---|
| EX-4.1 - ProUroCare Medical Inc. | v244225_ex4-1.htm |
| EX-99.2 - ProUroCare Medical Inc. | v244225_ex99-2.htm |
| EX-99.1 - ProUroCare Medical Inc. | v244225_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 22, 2011
ProUroCare Medical Inc.
(Exact Name of Registrant as Specified in its Charter)
|
Nevada
|
000-51774
|
20-1212923
|
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota 55416
|
||
|
(Address of Principal Executive Offices) (Zip Code)
|
||
|
(952) 476-9093
|
||
|
(Registrant’s Telephone Number, Including Area Code)
|
||
|
Not Applicable
|
||
|
(Former Name or Former Address, if Changed Since Last Report)
|
||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
||
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
||
Item 1.01 Entry into a Material Definitive Agreement
The disclosure under Item 2.03 below is incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Company
On December 22, 2011, ProUroCare Medical Inc. (the Company”) borrowed $40,000 from each of Larry Musich and Alisa Piazza pursuant to promissory notes. The unsecured promissory notes bear interest at 10% per annum and mature on March 22, 2012. In addition, pursuant to the terms of the Piazza note, the Company issued to the lender a five-year warrant to purchase 17,500 shares of the Company’s common stock at $1.30 per share.
Item 9.01 Financial Statements and Exhibits.
|
(c)
|
Exhibits
|
|
4.1
|
Warrant to acquire 17,500 shares of common stock issued in favor of Alisa Piazza dated December 22, 2011(filed herewith).
|
|
99.1
|
Promissory note dated December 22, 2011 issued in favor of Larry Musich (filed herewith).
|
|
99.2
|
Promissory note dated December 22, 2011 issued in favor of Alisa Piazza (filed herewith).
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
ProUroCare Medical Inc.
|
|||
|
Date: December 28, 2011
|
By:
|
/s/ Richard C. Carlson | |
|
Richard C. Carlson
Chief Executive Officer
|
|||